What is it about?
Strategies to modulate viral replication specific for each tumor microenvironment.
Featured Image
Why is it important?
It brings the promoter-specific strategies characteristic of the possibility that DNA-viruses bioengineer can provide.
Perspectives
The work with adenoviruses as a cancer treatment is still in pre-clinical research, the significant barrier to overcome to translate this virotherapy resides in delivery strategies.
Raquel Yokoda
Mayo Clinic
Read the Original
This page is a summary of: Oncolytic Adenoviruses in Gastrointestinal Cancers, Biomedicines, March 2018, MDPI AG,
DOI: 10.3390/biomedicines6010033.
You can read the full text:
Contributors
The following have contributed to this page
